|
Suppliers for CAS
870281-82-6
|
Properties | | CAS |
870281-82-6 | | Formula |
C22H18FN7O |
|
9 Registered suppliers
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
More details are to be found here
Capot Chemical Co., Ltd.
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C22H18FN7O
Molecular Weight: 415.4230232
HS Code: 29399990
Aea.ltd
P.R.China
Molecular Formula: C22H18FN7O
Molecular Weight: 415.4230232
HS Code: 29399990
Molecular Formula: C22H18FN7O
Molecular Weight: 415.4230232
HS Code: 29399990
Molecular Formula: C22H18FN7O
Molecular Weight: 415.4230232
HS Code: 29399990
Hangzhou Lingrui Chemical Co., Ltd.
P.R.China
Molecular Formula: C22H18FN7O
Molecular Weight: 415.4230232
HS Code: 29399990
BOC Sciences
USA
Description : Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL). - Molecular Weight :415.432
- Melting Point :250-252ēC
- Purity :> 95%
Molecular Formula : C22H18FN7O Canonical SMILES : CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
InChI :
InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1
InChIKey :
IFSDAJWBUCMOAH-HNNXBMFYSA-N
Solubility :
pH-dependent solubility ranging from <0.1 mg/mL at pH 5-7 to over 1 mg/mL at pH 2 under ambient conditions
Appearance :
Pale Brown Solid
Application :
the treatment of chronic lymphocytic leukemia (CLL)
Synonyms :
Idelalisib; CAL101; CAL 101; CAL-101; GS1101; GS 1101; GS-1101, Idelalisib.
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL). - Molecular Weight :415.432
- Melting Point :250-252ēC
- Purity :> 95%
Molecular Formula : C22H18FN7O Canonical SMILES : CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
InChI :
InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1
InChIKey :
IFSDAJWBUCMOAH-HNNXBMFYSA-N
Solubility :
pH-dependent solubility ranging from <0.1 mg/mL at pH 5-7 to over 1 mg/mL at pH 2 under ambient conditions
Appearance :
Pale Brown Solid
Application :
the treatment of chronic lymphocytic leukemia (CLL)
Synonyms :
Idelalisib; CAL101; CAL 101; CAL-101; GS1101; GS 1101; GS-1101, Idelalisib.
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL). - Molecular Weight :415.432
- Melting Point :250-252ēC
- Purity :> 95%
Molecular Formula : C22H18FN7O Canonical SMILES : CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
InChI :
InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1
InChIKey :
IFSDAJWBUCMOAH-HNNXBMFYSA-N
Solubility :
pH-dependent solubility ranging from <0.1 mg/mL at pH 5-7 to over 1 mg/mL at pH 2 under ambient conditions
Appearance :
Pale Brown Solid
Application :
the treatment of chronic lymphocytic leukemia (CLL)
Synonyms :
Idelalisib; CAL101; CAL 101; CAL-101; GS1101; GS 1101; GS-1101, Idelalisib.
More details are to be found here
Detailed information on the suppliers of
Idelalisib |
details
details